JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling
CanadaJAMP Venlafaxine XR 37.5 mg capsules; Mislabelling
Recalling Firm: Drugs and health products
Reason for Recall / Hazard
Labelling
Product Description & Identification
Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
Affected Products
JAMP Venlafaxine XR 37.5 mg capsules
Additional Source Details
| Field | Value |
|---|---|
| N I D | 73865 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/jamp-venlafaxine-xr-375-mg-capsules-mislabelling |
| Issue | Labelling |
| Title | JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling |
| Product | JAMP Venlafaxine XR 37.5 mg capsules |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-06-22 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada. |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmDrugs and health products
- Risk LevelType I
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Drugs and health products - JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling Check if your household is affected: https://therecallfile.com/recalls/jamp-venlafaxine-xr-37-5-mg-capsules-mislabelling/CANADA-73865
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Related Recalls
Health CanadaTransport Canada Recall - 2018088 -
Transport Canada Recall - 2018088 -
Tires
Health CanadaTransport Canada Recall - 2018288 -
Transport Canada Recall - 2018288 -
Airbag
Health CanadaTransport Canada Recall - 2018409 -
Transport Canada Recall - 2018409 -
Airbag